Abstract
Though self-paced walking is highly stereotyped, the stride interval fluctuates from one stride to the next around an average value with a measurable statistical variability. In clinical gait analysis, this variability is usually assessed with indices such the standard deviation or the coefficient of variation (CV). The aim of this study is to understand the added value that nonlinear indices of walking stride interval variability, such as Hurst exponent (H) and Minkowski fractal dimension (D), can provide in a clinical context and to suggest a clinical significance of these indices in the most common neurodegenerative diseases: Parkinson, Huntington, and amyotrophic lateral sclerosis. Although evidence have been accumulated that the stride interval organization at long range displays a more random, less autocorrelated, gait pattern in neurodegenerative diseases compared with young healthy individuals, it is today necessary to recompute CV, H, and D indices in a unified way and to take into account aging impact on these indices. In fact, computed nonlinear indices of variability are mainly dependent on stride interval time series length and algorithms used, making quantitative comparisons between different studies difficult or even impossible. Here, we recompute these indices from available stride interval time series, either coming from our lab or from online databases, or made available to us by the authors of previously conducted research. We confirm that both linear and nonlinear variability indices are relevant indicators of aging process and neurodegenerative diseases. CV is sensitive to aging process and pathology but does not allow to discriminate between specific neurodegenerative diseases. D shows no significative change in pathological groups. However, since H index is correlated with Hoehn & Yahr scores and significantly lowered in patients suffering from Huntington’s disease, we recommend it as a relevant supplement to CV.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received to support this work.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
buisseretf{at}helha.be, Charlotte.vandevoorde26{at}gmail.com, frederic.chantraine{at}rehazenter.lu, olivier.white{at}u-bourgogne.fr
Data Availability
All data referred in the manuscript are available.
